All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity
The pandemic of COVID-19 caused by SARS-CoV-2 continues to spread despite the global efforts taken to control it. The 3C-like protease (3CLpro), the major protease of SARS-CoV-2, is one of the most interesting targets for antiviral drug development because it is highly conserved among SARS-CoVs and...
Main Authors: | Takeshi Morita, Kei Miyakawa, Sundararaj Stanleyraj Jeremiah, Yutaro Yamaoka, Mitsuru Sada, Tomoko Kuniyoshi, Jinwei Yang, Hirokazu Kimura, Akihide Ryo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/8/1669 |
Similar Items
-
Currently Available Non-Balloon Devices
by: Hang Lak Lee
Published: (2018-09-01) -
Fragility of randomized trials supporting cancer drug approvals stratified by approval pathway and review designations
by: Brooke E. Wilson, et al.
Published: (2021-08-01) -
Drugs and Devices
by: Gail A. Van Norman, MD
Published: (2016-08-01) -
Comparison of approval procedures for medical devices in Europe and the USA
by: Vila Wagner Marcel, et al.
Published: (2019-09-01) -
Drugs, Devices, and the FDA: Part 1
by: Gail A. Van Norman, MD
Published: (2016-04-01)